These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


196 related items for PubMed ID: 1697805

  • 1. Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes.
    Schröder H, Ney P, Woditsch I, Schrör K.
    Eur J Pharmacol; 1990 Jul 03; 182(2):211-8. PubMed ID: 1697805
    [Abstract] [Full Text] [Related]

  • 2. Nitrovasodilator-induced inhibition of LTB4 release from human PMN may be mediated by cyclic GMP.
    Ney P, Schröder H, Schrör K.
    Eicosanoids; 1990 Jul 03; 3(4):243-5. PubMed ID: 1963541
    [Abstract] [Full Text] [Related]

  • 3. Differential inhibition and potentiation by cell-permeant analogues of cyclic AMP and cyclic GMP and NO-containing compounds of exocytosis in human neutrophils.
    Wenzel-Seifert K, Ervens J, Seifert R.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct 03; 344(4):396-402. PubMed ID: 1722562
    [Abstract] [Full Text] [Related]

  • 4. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH, Haslam RJ.
    Mol Pharmacol; 1990 May 03; 37(5):671-81. PubMed ID: 2160060
    [Abstract] [Full Text] [Related]

  • 5. Cyclic guanosine 3',5'-monophosphate mediates 3-morpholinosydnonimine-induced inhibition of human natural killer cells.
    Xiao L, Nilsson CG, Eneroth PH.
    Biochem Pharmacol; 1995 Jul 17; 50(2):147-53. PubMed ID: 7543267
    [Abstract] [Full Text] [Related]

  • 6. The effects of the nitric oxide donors molsidomine and SIN-I on human polymorphonuclear leucocyte function in vitro and ex vivo.
    Darius H, Grodzinska L, Meyer J.
    Eur J Clin Pharmacol; 1992 Jul 17; 43(6):629-33. PubMed ID: 1337322
    [Abstract] [Full Text] [Related]

  • 7. Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood; role for cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1.
    Bowen R, Haslam RJ.
    J Cardiovasc Pharmacol; 1991 Mar 17; 17(3):424-33. PubMed ID: 1711604
    [Abstract] [Full Text] [Related]

  • 8. The nitric oxide donor SIN-1 is free of tolerance and maintains its cyclic GMP stimulatory potency in nitrate-tolerant LLC-PK1 cells.
    Hinz B, Schröder H.
    Pharm Res; 1999 May 17; 16(5):633-6. PubMed ID: 10350003
    [Abstract] [Full Text] [Related]

  • 9. 3-Morpholino-sydnonimine-induced suppression of human neutrophil degranulation is not mediated by cyclic GMP, nitric oxide or peroxynitrite: inhibition of the increase in intracellular free calcium concentration by N-morpholino-iminoacetonitrile, a metabolite of 3-morpholino-sydnonimine.
    Kankaanranta H, Knowles RG, Vuorinen P, Kosonen O, Holm P, Moilanen E.
    Mol Pharmacol; 1997 May 17; 51(5):882-8. PubMed ID: 9145927
    [Abstract] [Full Text] [Related]

  • 10. Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils.
    Wanikiat P, Woodward DF, Armstrong RA.
    Br J Pharmacol; 1997 Nov 17; 122(6):1135-45. PubMed ID: 9401778
    [Abstract] [Full Text] [Related]

  • 11. Modulation of the pharmacological actions of nitrovasodilators by methylene blue and pyocyanin.
    Gryglewski RJ, Zembowicz A, Salvemini D, Taylor GW, Vane JR.
    Br J Pharmacol; 1992 Aug 17; 106(4):838-45. PubMed ID: 1327388
    [Abstract] [Full Text] [Related]

  • 12. Role of the L-arginine-NO pathway and of cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery.
    Bucher B, Ouedraogo S, Tschöpl M, Paya D, Stoclet JC.
    Br J Pharmacol; 1992 Dec 17; 107(4):976-82. PubMed ID: 1334757
    [Abstract] [Full Text] [Related]

  • 13. Actions of 3-morpholinosydnonimin (SIN-1) on rabbit isolated penile erectile tissue.
    Holmquist F, Fridstrand M, Hedlund H, Andersson KE.
    J Urol; 1993 Oct 17; 150(4):1310-5. PubMed ID: 8396690
    [Abstract] [Full Text] [Related]

  • 14. The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro.
    Bath PM.
    Eur J Clin Pharmacol; 1993 Oct 17; 45(1):53-8. PubMed ID: 8405030
    [Abstract] [Full Text] [Related]

  • 15. Role of cyclic GMP on inhibition by nitric oxide donors of human eosinophil chemotaxis in vitro.
    Thomazzi SM, Moreira J, Marcondes S, De Nucci G, Antunes E.
    Br J Pharmacol; 2004 Feb 17; 141(4):653-60. PubMed ID: 14744805
    [Abstract] [Full Text] [Related]

  • 16. Synergistic inhibition of human polymorphonuclear function by prostaglandin E1 and linsidomine.
    Gladis-Villanueva M, Schrör K.
    J Pharm Pharmacol; 1996 Jul 17; 48(7):706-11. PubMed ID: 8866334
    [Abstract] [Full Text] [Related]

  • 17. Oxidative and adhesive responses of human neutrophils to nitrovasodilators in vitro: the role of protein kinases.
    Klink M, Tchorzewski H, Sulowska Z.
    Mediators Inflamm; 2003 Dec 17; 12(6):345-53. PubMed ID: 14668094
    [Abstract] [Full Text] [Related]

  • 18. Cyclic GMP as the mediator of molsidomine-induced vasodilatation.
    Kukovetz WR, Holzmann S.
    Eur J Pharmacol; 1986 Mar 11; 122(1):103-9. PubMed ID: 3007172
    [Abstract] [Full Text] [Related]

  • 19. SIN-1 stimulates the production of cyclic GMP but not cyclic AMP in porcine aortic endothelial cells.
    Schini VB, Vanhoutte PM.
    J Cardiovasc Pharmacol; 1989 Mar 11; 14 Suppl 11():S91-4. PubMed ID: 2484708
    [Abstract] [Full Text] [Related]

  • 20. Effects of Trolox C and SIN-1 on arachidonic acid metabolism and on cyclic GMP formation in leukocytes.
    Riutta A, Alanko J, Mucha I, Vapaatalo H.
    Eur J Pharmacol; 1994 Sep 12; 262(3):217-22. PubMed ID: 7813586
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.